Drugs@FDA Data Files
The FDA has released updated Drugs@FDA downloadable data files in ZIP format, including updated data definitions and an Entity Relationship Diagram (ERD).
Regulatory intelligence professionals, data scientists in the life sciences sector, and departments responsible for maintaining internal databases of FDA-approved products.
The update suggests a continued effort by the agency to maintain transparency and provide structured data for industry stakeholders. Regular updates to the ERD and data definitions are critical for departments that rely on automated or programmatic access to FDA approval data, as shifts in data architecture can impact internal regulatory tracking systems and compliance reporting workflows. Building internal systems based on the official ERD likely reduces the risk of data misalignment during regulatory submissions or market monitoring.
Information technology and regulatory intelligence teams should download the updated ZIP file and cross-reference the Entity Relationship Diagram (ERD) to ensure internal drug databases remain synchronized with FDA’s foundational record structure. Regulatory analysts may utilize the data definitions to refine internal data mapping protocols.
Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)
Open in openFDA / FDA.gov